. Author manuscript; available in PMC: 2023 Sep 27.

Published in final edited form as: J Clin Immunol. 2023 Apr 24;43(6):1311–1325. doi: 10.1007/s10875-023-01485-9

Table 1.

Patient cohort characteristics

Characteristics	Patients with CVID	Patients with GLILD	p value

No. of patients	12	23
Sex (Female %)	58%	75%
Age (range)	45 (17–63)	41 (22–67)	NS
Plasma IgM, mg/dL (range)	19 (5–87)	17 (4–66)	NS
Plasma IgA, mg/dL (range)	25 (0–177)	15 (0–5)
Plasma IgG, mg/dL (range)	203 (33–477)	217 (7–832)	NS
Absolute lymphocyte count (cells/mm³)	1109 (368–1569)	1288 (330–6909)	NS
CD4+ T cells (Abs)	512 (110–1101)	545 (1203–1324)	NS
CD8+ T cells (Abs)	397 (59–1217)	537 (64–4836)	NS
CD19+ B cells (Abs)	98 (0–246)	65 (0–553)	0.03
CD56+ NK cells (Abs)	85 (31–221)	113 (3–384)	NS
	1/12 (8%)	13/23 (61%)
Lymphadenopathy
Splenomegaly	6/12 (50%)	20/23 (87%)
Enteropathy	0/12 (0%)	1/23 (4%)
Autoimmune cymiddleenia	1/12 (8%)	6/23 (26%)